Hosted on MSN2mon
FDA-Approved Nasal Spray For Depression Is First Of Its KindA ketamine-based nasal spray is officially the first and only standalone therapy available for treatment-resistant depression in the US. The FDA first approved the Johnson & Johnson drug ...
We specialize in treatment resistant DEPRESSION ... Esketamine, branded as Spravato, also covered by insurance, is a nasal spray that works on different neurotransmitter systems in the brain ...
March 6, 2025 – The FDA has approved a new nose spray that can quickly ... Parents and caregivers should inform their child’s health care provider about any nasal issues, heart, kidney ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results